These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35328329)

  • 61. Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targets.
    Chen IJ; Neamati N; Nicklaus MC; Orr A; Anderson L; Barchi JJ; Kelley JA; Pommier Y; MacKerell AD
    Bioorg Med Chem; 2000 Oct; 8(10):2385-98. PubMed ID: 11058033
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIV-1 integrase: the next target for AIDS therapy?
    d'Angelo J; Mouscadet JF; Desmaële D; Zouhiri F; Leh H
    Pathol Biol (Paris); 2001 Apr; 49(3):237-46. PubMed ID: 11367559
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modeling HIV-1 integrase complexes based on their hydrodynamic properties.
    Podtelezhnikov AA; Gao K; Bushman FD; McCammon JA
    Biopolymers; 2003 Jan; 68(1):110-20. PubMed ID: 12579583
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Docking dinucleotides to HIV-1 integrase carboxyl-terminal domain to find possible DNA binding sites.
    Zhu HM; Chen WZ; Wang CX
    Bioorg Med Chem Lett; 2005 Jan; 15(2):475-7. PubMed ID: 15603976
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Binding modes of two novel dinucleotide inhibitors of HIV-1 integrase.
    Guenther S; Nair V
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2233-6. PubMed ID: 12127545
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular dynamics studies of the full-length integrase-DNA complex.
    De Luca L; Vistoli G; Pedretti A; Barreca ML; Chimirri A
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1010-6. PubMed ID: 16165087
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quinoline-based Protein-protein Interaction Inhibitors of LEDGF/p75 and HIV Integrase: An In Silico Study.
    Chhokar N; Kalra S; Chauhan M; Munshi A; Kumar R
    Curr Top Med Chem; 2018; 18(32):2800-2815. PubMed ID: 30747071
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Insight into the fundamental interactions between LEDGF binding site inhibitors and integrase combining docking and molecular dynamics simulations.
    De Luca L; Morreale F; Chimirri A
    J Chem Inf Model; 2012 Dec; 52(12):3245-54. PubMed ID: 23194297
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Ku70-binding site of Ku80 is required for the stabilization of Ku70 in the cytoplasm, for the nuclear translocation of Ku80, and for Ku80-dependent DNA repair.
    Koike M; Koike A
    Exp Cell Res; 2005 May; 305(2):266-76. PubMed ID: 15817152
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor.
    Gu WG; Ip DT; Liu SJ; Chan JH; Wang Y; Zhang X; Zheng YT; Wan DC
    Chem Biol Interact; 2014 Apr; 213():21-7. PubMed ID: 24480521
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity.
    Anstett K; Brenner B; Mesplède T; Wainberg MA
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835492
    [TBL] [Abstract][Full Text] [Related]  

  • 72. N-hydroxy-substituted 2-aryl acetamide analogs: A novel class of HIV-1 integrase inhibitors.
    Debnath U; Kumar P; Agarwal A; Kesharwani A; Gupta SK; Katti SB
    Chem Biol Drug Des; 2017 Oct; 90(4):527-534. PubMed ID: 28294572
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reduced HIV-1 integrase flexibility as a mechanism for raltegravir resistance.
    Dewdney TG; Wang Y; Kovari IA; Reiter SJ; Kovari LC
    J Struct Biol; 2013 Nov; 184(2):245-50. PubMed ID: 23891838
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxidative stress induces nuclear loss of DNA repair proteins Ku70 and Ku80 and apoptosis in pancreatic acinar AR42J cells.
    Song JY; Lim JW; Kim H; Morio T; Kim KH
    J Biol Chem; 2003 Sep; 278(38):36676-87. PubMed ID: 12867423
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors.
    Kessl JJ; Jena N; Koh Y; Taskent-Sezgin H; Slaughter A; Feng L; de Silva S; Wu L; Le Grice SF; Engelman A; Fuchs JR; Kvaratskhelia M
    J Biol Chem; 2012 May; 287(20):16801-11. PubMed ID: 22437836
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A quantum mechanic/molecular mechanic study of the wild-type and N155S mutant HIV-1 integrase complexed with diketo acid.
    Alves CN; Martí S; Castillo R; Andrés J; Moliner V; Tuñón I; Silla E
    Biophys J; 2008 Apr; 94(7):2443-51. PubMed ID: 17981909
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
    J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dual inhibitor design for HIV-1 reverse transcriptase and integrase enzymes: a molecular docking study.
    Ercan S; Şenyiğit B; Şenses Y
    J Biomol Struct Dyn; 2020 Feb; 38(2):573-580. PubMed ID: 31787027
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Close-up: HIV/SIV intasome structures shed new light on integrase inhibitor binding and viral escape mechanisms.
    Engelman AN; Cherepanov P
    FEBS J; 2021 Jan; 288(2):427-433. PubMed ID: 32506843
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Optimization of rhodanine scaffold for the development of protein-protein interaction inhibitors.
    Ferro S; De Luca L; Agharbaoui FE; Christ F; Debyser Z; Gitto R
    Bioorg Med Chem; 2015 Jul; 23(13):3208-14. PubMed ID: 25999203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.